maximum, min

Signalling cascade after agonist binding to GLP-1R (in vitro / in vivo animal model): Activation of the Gs protein leads to stimulation of adenylate cyclase, an increase in cAMP concentration, and activation of PKA and Epac2 In pancreatic -cells: the rise in cAMP leads to glucose-dependent insulin secretion an important distinction from sulfonylureas, which stimulate secretion independently of glucose concentration In POMC neurons of the hypothalamic arcuate nucleus: GLP-1R activation induces the release of -MSH onto MC4R receptors in the paraventricular nucleus satiety signalling and inhibition of food intake In NTS neurons of the brainstem: GLP-1R activation modulates afferent signalling from the vagus nerve slowing of gastric emptying In the mesolimbic circuit (ventral tegmental area, nucleus accumbens): modulation of dopaminergic signalling in response to caloric stimuli this is the mechanism underlying the observed reduction in preference for high-calorie foods in behavioural models In DIO mouse models (diet-induced obesity, C57BL/6J) chronic exposure to semaglutide (usually 1060 nmol/kg s.c., once every 23 days) led to a 1015% reduction in body weight relative to the control group over 46 weeks

Semaglutide improved symptoms, physical limitations, and led to greater weight loss across diuretic use categories in patients with HFpEF, says study author Kavita Sharma, MD, of Johns Hopkins University School of Medicine, in a release
Medicare Part D coverage expansion represents a USD 18.4 billion addressable GLP-1 market catalyst that could restructure U.S
pregnancies are unplanned. Pregnancy an exclusion criteria in trials, but pregnancies still occurred The SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) clinical trial program, which led to the FDA approval of semaglutide for type 2 diabetes treatment, excluded women who were pregnant, breastfeeding or intending to become pregnant
This paradoxical response reflects individual variation in how the gastrointestinal system responds to slowed gastric emptying and altered gut transit time